{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:30:19Z","timestamp":1787049019104,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yongchuan District Science and Technology Bureau Project","award":["No. 2025yc-cxfz10110"],"award-info":[{"award-number":["No. 2025yc-cxfz10110"]}]},{"name":"Scientific Research Project of Yongchuan Hospital of Chongqing Medical University","award":["No. YJL2025056"],"award-info":[{"award-number":["No. YJL2025056"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05555-3","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:25:19Z","timestamp":1783927519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A machine learning-guided epithelial plasticity score refines prognostication and immune-context stratification in muscle-invasive bladder cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Difei","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"5555_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"5555_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"The Cancer Genome Atlas Research Network","year":"2014","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507:315\u201322.","journal-title":"Nature"},{"key":"5555_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014;25:152\u201365.","journal-title":"Cancer Cell"},{"key":"5555_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ebiom.2016.08.036","volume":"12","author":"V Dadhania","year":"2016","unstructured":"Dadhania V, Zhang M, Zhang L, et al. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use. EBioMedicine. 2016;12:105\u201317.","journal-title":"EBioMedicine"},{"key":"5555_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reynies A, Allory Y, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol. 2020;77:420\u201333.","journal-title":"Eur Urol"},{"key":"5555_CR6","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/s41467-023-37568-9","volume":"14","author":"AG Robertson","year":"2023","unstructured":"Robertson AG, Meghani K, Cooley LF, et al. Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer. Nat Commun. 2023;14:2126.","journal-title":"Nat Commun"},{"key":"5555_CR7","doi-asserted-by":"publisher","first-page":"103972","DOI":"10.1016\/j.esmoop.2024.103972","volume":"9","author":"JE Rosenberg","year":"2024","unstructured":"Rosenberg JE, Galsky MD, Powles T, et al. Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial. ESMO Open. 2024;9:103972.","journal-title":"ESMO Open"},{"key":"5555_CR8","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.ccell.2024.10.016","volume":"42","author":"H Hamidi","year":"2024","unstructured":"Hamidi H, Senbabaoglu Y, Beig N, et al. Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade. Cancer Cell. 2024;42:2098\u2013e21124.","journal-title":"Cancer Cell"},{"key":"5555_CR9","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1038\/s41467-018-05992-x","volume":"9","author":"L Wang","year":"2018","unstructured":"Wang L, Saci A, Szabo PM, et al. EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer. Nat Commun. 2018;9:3503.","journal-title":"Nat Commun"},{"key":"5555_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, et al. TGF-beta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554:544\u20138.","journal-title":"Nature"},{"key":"5555_CR11","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1158\/1078-0432.CCR-20-4796","volume":"27","author":"H Wang","year":"2021","unstructured":"Wang H, Mei Y, Luo C, et al. Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial-Mesenchymal Transition in Recurrent Bladder Cancer. Clin Cancer Res. 2021;27:6265\u201378.","journal-title":"Clin Cancer Res"},{"key":"5555_CR12","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s13402-023-00820-x","volume":"46","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Wang X, Yang X, et al. Single-cell RNA sequencing reveals the cellular and molecular characteristics of high-grade and metastatic bladder cancer. Cell Oncol (Dordr). 2023;46:1415\u201327.","journal-title":"Cell Oncol (Dordr)"},{"key":"5555_CR13","doi-asserted-by":"publisher","first-page":"101201","DOI":"10.1016\/j.isci.2020.101201","volume":"23","author":"G Yang","year":"2020","unstructured":"Yang G, Bondaruk J, Cogdell D, et al. Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer. iScience. 2020;23:101201.","journal-title":"iScience"},{"key":"5555_CR14","doi-asserted-by":"publisher","first-page":"e006643","DOI":"10.1136\/jitc-2022-006643","volume":"11","author":"Y Song","year":"2023","unstructured":"Song Y, Peng Y, Qin C, et al. Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment. J Immunother Cancer. 2023;11:e006643.","journal-title":"J Immunother Cancer"},{"key":"5555_CR15","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"5555_CR16","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133.","journal-title":"Bioinformatics"},{"key":"5555_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"key":"5555_CR18","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2:100141.","journal-title":"Innov (Camb)"},{"key":"5555_CR19","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5555_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"5555_CR21","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"5555_CR22","doi-asserted-by":"publisher","first-page":"e26476","DOI":"10.7554\/eLife.26476","volume":"6","author":"J Racle","year":"2017","unstructured":"Racle J, de Jonge K, Baumgaertner P, et al. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. eLife. 2017;6:e26476.","journal-title":"eLife"},{"key":"5555_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello F, Mayer C, Plattner C, et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019;11:34.","journal-title":"Genome Med"},{"key":"5555_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.","journal-title":"Genome Biol"},{"key":"5555_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie DA, Tamayo P, Boehm JS, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462:108\u201312.","journal-title":"Nature"},{"key":"5555_CR26","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u2013e358729.","journal-title":"Cell"},{"key":"5555_CR27","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396.","journal-title":"Nat Methods"},{"key":"5555_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41587-021-01091-3","volume":"40","author":"D Sun","year":"2022","unstructured":"Sun D, Wang J, Han Y, et al. Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nat Biotechnol. 2022;40:527\u201338.","journal-title":"Nat Biotechnol"},{"key":"5555_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh I, Izar B, Prakadan SM, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352:189\u201396.","journal-title":"Science"},{"key":"5555_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","volume":"566","author":"J Cao","year":"2019","unstructured":"Cao J, Spielmann M, Qiu X, et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature. 2019;566:496\u2013502.","journal-title":"Nature"},{"key":"5555_CR31","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1038\/s41592-025-02857-2","volume":"22","author":"M Kang","year":"2025","unstructured":"Kang M, Gulati GS, Brown EL, et al. Improved reconstruction of single-cell developmental potential with CytoTRACE 2. Nat Methods. 2025;22:2258\u201363.","journal-title":"Nat Methods"},{"key":"5555_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18:248\u201362.","journal-title":"Cell Rep"},{"key":"5555_CR33","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24:1550\u20138.","journal-title":"Nat Med"},{"key":"5555_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337\u201344.","journal-title":"Biometrics"},{"key":"5555_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak. 2006;26:565\u201374.","journal-title":"Med Decis Mak"},{"key":"5555_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskjot","year":"2023","unstructured":"Dyrskjot L, Hansel DE, Efstathiou JA, et al. Bladder cancer. Nat Rev Dis Primers. 2023;9:58.","journal-title":"Nat Rev Dis Primers"},{"key":"5555_CR37","doi-asserted-by":"publisher","first-page":"a041389","DOI":"10.1101\/cshperspect.a041389","volume":"14","author":"JR Pitarresi","year":"2024","unstructured":"Pitarresi JR, Stanger BZ. Cellular origins and lineage plasticity in cancer. Cold Spring Harb Perspect Med. 2024;14:a041389.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5555_CR38","doi-asserted-by":"publisher","first-page":"e2303230","DOI":"10.1002\/advs.202303230","volume":"10","author":"T Liang","year":"2023","unstructured":"Liang T, Tao T, Wu K, et al. Cancer-associated fibroblast-induced remodeling of tumor microenvironment in recurrent bladder cancer. Adv Sci (Weinh). 2023;10:e2303230.","journal-title":"Adv Sci (Weinh)"},{"key":"5555_CR39","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41419-024-07298-x","volume":"15","author":"CC Tu","year":"2024","unstructured":"Tu CC, Hsieh TH, Chu CY, et al. Targeting PPAR-gamma via SIAH1\/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer. Cell Death Dis. 2024;15:897.","journal-title":"Cell Death Dis"},{"key":"5555_CR40","doi-asserted-by":"publisher","first-page":"156287","DOI":"10.1016\/j.prp.2025.156287","volume":"277","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Ye S, Wang S, et al. SCD1 drives bladder cancer progression and trametinib sensitivity. Pathol Res Pract. 2026;277:156287.","journal-title":"Pathol Res Pract"},{"key":"5555_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12967-024-04867-8","volume":"22","author":"L Zhou","year":"2024","unstructured":"Zhou L, Du K, Dai Y, et al. Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer. J Transl Med. 2024;22:55.","journal-title":"J Transl Med"},{"key":"5555_CR42","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1158\/2326-6066.CIR-23-1105","volume":"12","author":"M Praharaj","year":"2024","unstructured":"Praharaj M, Shen F, Lee AJ, et al. Metabolic reprogramming of tumor-associated macrophages using glutamine antagonist JHU083 drives tumor immunity in myeloid-rich prostate and bladder cancers. Cancer Immunol Res. 2024;12:854\u201375.","journal-title":"Cancer Immunol Res"},{"key":"5555_CR43","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","volume":"9","author":"A Chakravarthy","year":"2018","unstructured":"Chakravarthy A, Khan L, Bensler NP, et al. TGF-beta-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure. Nat Commun. 2018;9:4692.","journal-title":"Nat Commun"},{"key":"5555_CR44","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1158\/1535-7163.MCT-22-0130","volume":"21","author":"H Yu","year":"2022","unstructured":"Yu H, Sfakianos JP, Wang L, et al. Tumor-infiltrating myeloid cells confer de novo resistance to PD-L1 blockade through EMT-stromal and TGFbeta-dependent mechanisms. Mol Cancer Ther. 2022;21:1729\u201341.","journal-title":"Mol Cancer Ther"},{"key":"5555_CR45","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1186\/s12885-022-09788-7","volume":"22","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Zhang W, Lin T, et al. Mass cytometry reveals immune atlas of urothelial carcinoma. BMC Cancer. 2022;22:677.","journal-title":"BMC Cancer"},{"key":"5555_CR46","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41416-023-02552-z","volume":"130","author":"Y Ouyang","year":"2024","unstructured":"Ouyang Y, Zhong W, Xu P, et al. Tumor-associated neutrophils suppress CD8\u2009+\u2009T cell immunity in urothelial bladder carcinoma through the COX-2\/PGE2\/IDO1 Axis. Br J Cancer. 2024;130:880\u201391.","journal-title":"Br J Cancer"},{"key":"5555_CR47","doi-asserted-by":"publisher","first-page":"109928","DOI":"10.1016\/j.isci.2024.109928","volume":"27","author":"L Wang","year":"2024","unstructured":"Wang L, Izadmehr S, Sfakianos JP, et al. Single-cell transcriptomic-informed deconvolution of bulk data identifies immune checkpoint blockade resistance in urothelial cancer. iScience. 2024;27:109928.","journal-title":"iScience"},{"key":"5555_CR48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00262-024-03839-7","volume":"74","author":"M Cho","year":"2024","unstructured":"Cho M, Chang H, Kim JH. Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors. Cancer Immunol Immunother. 2024;74:28.","journal-title":"Cancer Immunol Immunother"},{"key":"5555_CR49","doi-asserted-by":"publisher","first-page":"e2308438","DOI":"10.1002\/advs.202308438","volume":"11","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Jin W, Qian K, et al. Integrative single-cell atlas revealed intratumoral heterogeneity generation from an adaptive epigenetic cell state in human bladder urothelial carcinoma. Adv Sci (Weinh). 2024;11:e2308438.","journal-title":"Adv Sci (Weinh)"},{"key":"5555_CR50","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13046-023-02900-0","volume":"42","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Yu Y, Zhang Z, et al. Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1. J Exp Clin Cancer Res. 2023;42:316.","journal-title":"J Exp Clin Cancer Res"},{"key":"5555_CR51","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s12672-025-03244-1","volume":"16","author":"J Peng","year":"2025","unstructured":"Peng J, Li D, Xiang B, et al. Knockdown of CSF1R molecules enhances the antitumor effects of CD8\u2009+\u2009T lymphocytes in bladder cancer. Discov Oncol. 2025;16:1426.","journal-title":"Discov Oncol"},{"key":"5555_CR52","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1186\/s12967-025-06682-1","volume":"23","author":"Z Wang","year":"2025","unstructured":"Wang Z, Zhou Z, Yang S, et al. Pathway-based cancer transcriptome deciphers a high-resolution intrinsic heterogeneity within bladder cancer classification. J Transl Med. 2025;23:666.","journal-title":"J Transl Med"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05555-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05555-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05555-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:14:33Z","timestamp":1787048073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05555-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5555"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05555-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"25 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All analyses were based exclusively on publicly available, de-identified datasets; therefore, no additional institutional ethics approval was required. This study was conducted in accordance with the ethical principles of the Declaration of Helsinki and with all applicable guidelines and regulations for secondary analysis of public de-identified data. This study used only publicly available, de-identified datasets and did not involve direct contact with human participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not contain any individual person\u2019s identifiable data.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1203"}}